Key Developments: Vitamin Shoppe Inc (VSI.N)

VSI.N on New York Stock Exchange

49.11USD
1:29pm EDT
Price Change (% chg)

$0.95 (+1.97%)
Prev Close
$48.16
Open
$48.26
Day's High
$49.11
Day's Low
$48.14
Volume
15,998
Avg. Vol
120,157
52-wk High
$65.92
52-wk Low
$43.16

Search Stocks

Latest Key Developments (Source: Significant Developments)

Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors Of Deadline In Securities Class Action Lawsuit Against Vitamin Shoppe Inc
Friday, 5 Jul 2013 10:00pm EDT 

Kahn Swick & Foti, LLC (KSF) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminded investors with large financial interests that they have only until July 8, 2013 to file lead plaintiff applications in a securities class action lawsuit against Vitamin Shoppe Inc. Investor losses must relate to purchases of the Company's common stock during the period between May 8, 2012 and February 25, 2013, inclusive. This action is pending in the United States District Court for the District of New Jersey.  Full Article

Levi & Korsinsky Notifies Investors with Losses On Their Investment In Vitamin Shoppe Inc. Of Class Action Lawsuit And Deadline Of July 8, 2013 To Seek Lead Plaintiff Position
Monday, 24 Jun 2013 04:09pm EDT 

Levi & Korsinsky announced that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Vitamin Shoppe, Inc. (Vitamin Shoppe or the Company) stock between May 8, 2012 and February 25, 2013 (the Class Period). The complaint alleges that during the Class Period, defendants issued materially false and misleading statements and omitted materially relevant facts regarding the Company`s operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: (a) Vitamin Shoppe`s business was being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (b) GNC`s new discount program was negatively impacting the Company`s sales growth; (c) the Company was experiencing declining same-store sales trends; and (d) that as a result of the aforementioned, Vitamin Shoppe stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their Vitamin Shoppe common stock at inflated prices during the Class Period.  Full Article

Lifshitz Law Firm Announces Investigation Of Vitamin Shoppe Inc
Tuesday, 28 May 2013 09:13pm EDT 

Lifshitz Law Firm announced that a class action suit was filed in the United States District Court for the District of New Jersey, alleging that Vitamin Shoppe Inc issued false and misleading statements to investors between May 8, 2012 and February 25, 2013, inclusive (the Class Period) by failing to adequately disclose (i) Vitamin Shoppe's business was negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC's new discount program was negatively impacting Vitamin Shoppe's sales growth; and (iii) Vitamin Shoppe was experiencing declining same-store sales trends. The firm is investigating legal claims against the officers and Board of Directors of Vitamin Shoppe.  Full Article

Glancy Binkow & Goldberg LLP Announces Investigation Of Vitamin Shoppe Inc
Tuesday, 14 May 2013 09:32pm EDT 

Glancy Binkow & Goldberg LLP announced that it is investigating potential claims on behalf of shareholders of Vitamin Shoppe, Inc. concerning possible breaches of fiduciary duties by the Company or fiduciaries. The investigation focuses on certain statements issued by Vitamin Shoppe between May 8, 2012 and February 25, 2013 concerning the Company's business and financial prospects.  Full Article

Bernstein Liebhard LLP Announces Class Action Against Vitamin Shoppe Inc
Thursday, 9 May 2013 03:41pm EDT 

Bernstein Liebhard LLP announced that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of a class (the Class) of purchasers of Vitamin Shoppe, Inc. (Vitamin Shoppe or the Company) common stock between May 8, 2012 and February 25, 2013. The complaint charges Vitamin Shoppe and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Vitamin Shoppe, through its subsidiaries, operates as a specialty retailer and direct marketer of nutritional products in the United States. The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company's operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: (i) Vitamin Shoppe's business was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC's new discount program was negatively impacting the Company's sales growth; and (iii) the Company was experiencing declining same-store sales trends. As a result of defendants' false and misleading statements, Vitamin Shoppe common stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their personally held Vitamin Shoppe common stock at inflated prices during the Class Period.  Full Article

Briscoe Law and Powers Taylor Investigate Possible Breaches of fiduciary duty by Officers And Directors OF Vitamin Shoppe Inc
Thursday, 9 May 2013 10:22am EDT 

Briscoe Law and Powers Taylor announced that a federal class action lawsuit has been filed against Vitamin Shoppe, Inc. (Vitamin Shoppe or Company). The firms are investigating additional legal claims against the officers and Board of Directors of Vitamin Shoppe during the period of May 8, 2012 and February 25, 2013 (the Class Period). Specifically, the complaint alleges that among other things, defendants misrepresented and/or failed to disclose that: Vitamin Shoppe was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; GNC`s new discount program was negatively impacting the Company`s sales growth; and the Company was experiencing declining same-store sales trends. According to the complaint, when the true facts came to light and the Company announced poor financial results for it`s fiscal and fourth quarter 2012, the price of the stock fell substantially.  Full Article

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Vitamin Shoppe Inc
Wednesday, 8 May 2013 04:57pm EDT 

Ryan & Maniskas, LLP announced that class action has been filed in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe Inc common stock during the period between May 8, 2012 and February 25, 2013 (the "Class Period").  Full Article

Bronstein, Gewirtz & Grossman, LLC Announces Class Action Lawsuit Against Vitamin Shoppe Inc
Wednesday, 8 May 2013 08:30am EDT 

Bronstein, Gewirtz & Grossman, LLC announced that a class action law suit was filed in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe, Inc. (Vitamin Shoppe or the Company) common stock between May 8, 2012 and February 25, 2013 inclusive (the Class Period). The complaint charges Vitamin Shoppe and certain of its officers and directors with violations of the Securities Exchange Act of 1934.  Full Article

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Vitamin Shoppe Inc
Tuesday, 7 May 2013 01:46pm EDT 

Robbins Geller Rudman & Dowd LLP (Robbins Geller) announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe, Inc. (Vitamin Shoppe) common stock during the period between May 8, 2012 and February 25, 2013 (the Class Period). The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company`s operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: (i) Vitamin Shoppe`s business was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC`s new discount program was negatively impacting the Company`s sales growth; and (iii) the Company was experiencing declining same-store sales trends. As a result of defendants` false and misleading statements, Vitamin Shoppe common stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their personally held Vitamin Shoppe common stock at inflated prices during the Class Period.  Full Article

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Vitamin Shoppe Inc
Tuesday, 7 May 2013 01:46pm EDT 

Robbins Geller Rudman & Dowd LLP (Robbins Geller) announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Vitamin Shoppe, Inc. (Vitamin Shoppe) common stock during the period between May 8, 2012 and February 25, 2013 (the Class Period). The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company`s operations, business trends and same-store sales trends. Specifically, defendants failed to disclose that: (i) Vitamin Shoppe`s business was then being negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC`s new discount program was negatively impacting the Company`s sales growth; and (iii) the Company was experiencing declining same-store sales trends. As a result of defendants` false and misleading statements, Vitamin Shoppe common stock traded at artificially inflated prices, enabling Company insiders to sell more than $30 million of their personally held Vitamin Shoppe common stock at inflated prices during the Class Period.  Full Article

Vitamin Shoppe revenue growth skids; shares slide

- Nutritional products retailer Vitamin Shoppe Inc's revenue missed analysts' estimates for the first time in several quarters, hurt by the impact of superstorm Sandy, sending its shares down 19 percent.

Search Stocks